Case Studies

Resistance to antibiotic treatments are responsible for approximately 33,000 deaths a year in Europe and infectious diseases were the leading cause of death among children under five. This includes bacteria that have developed resistance to Carbapenems, considered drugs of ‘last resort’ for Antimicrobial Resistance (AMR) infect...

In 2020, 2.7 million people in the European Union were diagnosed with cancer and 1.3 million lives were lost to the disease. The EU Commission supports research to improve prevention, detection, diagnosis and treatment of cancer. Quality of life for patients during treatment is also a priority, and is an important factor for ev...

Infusion pumps, also known as syringe pumps, are used to automatically deliver critical fluids to patients at precisely programmed rates or intervals. When these devices are used to administer high-risk medications, inaccuracies in delivered flow rates can have significant safety implications; especially for drugs with narrow ...

Over a third of all deaths in the EU are caused by disorders of the heart or blood vessels collectively described as cardiovascular disease (CVD), making it the leading cause of mortality. As well as the significant social toll, CVD is also estimated to cost the EU economy around €210 billion a year. The current ‘gold standard’...

More than 500 000 medical devices are on sale in Europe, generating around €51 billion annually and accounting for one third of the market worldwide. This sector could potentially benefit from the rapidly expanding additive manufacturing (AM) industry. Commonly known as 3D printing this technique could allow the low-cost fabric...

Around 22.6 million people in the EU live with untreated, disabling hearing loss. As well as its social effects it also costs the European economy around €185 billion each year, €25 billion more than the EU budget for 2018. In Germany four to five million workers are exposed to harmful occupational noise and the German social a...